Philip joined Step Pharma in June 2021. Prior to this, he held diverse leadership roles in early stage biotech and small pharma covering oncology drug development and biomarker discovery, with a focus on the use of complex omics technologies to accelerate both the discovery and development of novel therapeutics. Philip is a board certified haematologist with 16 years frontline healthcare experience; he holds a licence to practice in the UK.
Philip is a Member of the Royal College of Physicians, UK, and a Fellow of the Royal College of Pathologists, UK. He was awarded a PhD in molecular cancer biology from the University of Cambridge, UK, and followed this with post-doctoral research at the BC Cancer Agency, Vancouver, Canada. He is an Honorary Professor of Translational Medical at the Hull York Medical School, UK.